JPMorgan Chase & Co’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15 Buy
+3
New +$15 ﹤0.01% 6077
2024
Q3
Sell
-1
Closed -$8 6495
2024
Q2
$8 Hold
1
﹤0.01% 6200
2024
Q1
$22 Hold
1
﹤0.01% 6145
2023
Q4
$14 Sell
1
-304
-100% -$4.26K ﹤0.01% 6355
2023
Q3
$6.03K Sell
305
-16,113
-98% -$318K ﹤0.01% 5403
2023
Q2
$1.26M Sell
16,418
-365
-2% -$27.9K ﹤0.01% 3291
2023
Q1
$1.59M Buy
16,783
+6
+0% +$567 ﹤0.01% 3176
2022
Q4
$1.63M Sell
16,777
-58
-0.3% -$5.65K ﹤0.01% 3084
2022
Q3
$4.34M Sell
16,835
-11,288
-40% -$2.91M ﹤0.01% 2430
2022
Q2
$5.23M Buy
28,123
+6,253
+29% +$1.16M ﹤0.01% 2374
2022
Q1
$2.14M Sell
21,870
-2,552
-10% -$250K ﹤0.01% 3125
2021
Q4
$3.99M Sell
24,422
-61
-0.2% -$9.97K ﹤0.01% 2735
2021
Q3
$6.69M Sell
24,483
-7,747
-24% -$2.12M ﹤0.01% 2372
2021
Q2
$12.8M Sell
32,230
-2,853
-8% -$1.13M ﹤0.01% 1956
2021
Q1
$18.9M Buy
35,083
+17,656
+101% +$9.53M ﹤0.01% 1641
2020
Q4
$6.59M Buy
17,427
+5,266
+43% +$1.99M ﹤0.01% 2228
2020
Q3
$4.69M Buy
12,161
+2,578
+27% +$994K ﹤0.01% 2256
2020
Q2
$4.71M Buy
9,583
+5,703
+147% +$2.81M ﹤0.01% 2188
2020
Q1
$1.43M Buy
3,880
+2,283
+143% +$839K ﹤0.01% 2778
2019
Q4
$1.13M Buy
1,597
+1,246
+355% +$882K ﹤0.01% 2994
2019
Q3
$225K Buy
351
+57
+19% +$36.5K ﹤0.01% 3699
2019
Q2
$253K Buy
294
+79
+37% +$68K ﹤0.01% 3680
2019
Q1
$124K Sell
215
-10
-4% -$5.77K ﹤0.01% 3943
2018
Q4
$63K Buy
225
+21
+10% +$5.88K ﹤0.01% 4189
2018
Q3
$98K Buy
204
+25
+14% +$12K ﹤0.01% 4130
2018
Q2
$81K Sell
179
-91
-34% -$41.2K ﹤0.01% 4149
2018
Q1
$159K Buy
270
+80
+42% +$47.1K ﹤0.01% 3789
2017
Q4
$117K Buy
190
+189
+18,900% +$116K ﹤0.01% 3851
2017
Q3
$1K Hold
1
﹤0.01% 4245
2017
Q2
$1K Sell
1
-520
-100% -$520K ﹤0.01% 4276
2017
Q1
$495K Sell
521
-825
-61% -$784K ﹤0.01% 3155
2016
Q4
$1.08M Buy
+1,346
New +$1.08M ﹤0.01% 2957
2016
Q3
Sell
-4
Closed -$3K 4247
2016
Q2
$3K Buy
+4
New +$3K ﹤0.01% 4040
2016
Q1
Sell
-3
Closed -$3K 4276
2015
Q4
$3K Buy
+3
New +$3K ﹤0.01% 3853
2013
Q4
Sell
-245
Closed -$145K 3760
2013
Q3
$145K Sell
245
-341
-58% -$202K ﹤0.01% 3718
2013
Q2
$185K Buy
+586
New +$185K ﹤0.01% 3562